Transformative AI healthcare stocks sit at the crossroads of powerful trends in medicine and technology, just as inflation, energy volatility, and uncertain rate paths keep broader markets on edge. While central banks weigh policy shifts and trade flows adjust to new cost pressures, AI in healthcare targets something more fundamental: better diagnostics, more tailored treatments, and leaner hospital operations. This screener focuses on companies using AI to improve accuracy, access, and affordability in care, ranging from research labs to remote monitoring. In this article, you will see three stocks from the Transformative AI Healthcare screener that may be worth a closer look.
ASO International (TSE:9340)
Overview: ASO International is a Japan based dental orthodontics company that develops and supplies a wide range of specialist products, from clear aligners and lingual braces to 3D printers, AI powered scanning tools, and digital modeling services for clinics and labs.
Market Cap: ¥6.9b
ASO International sits at an intersection of AI, 3D printing, and orthodontic treatment, with tools like its WE SCAN AI correction system and ASO Digital 3D printing services aimed at making treatment planning more precise and efficient. The current share price is assessed as below estimated fair value on standard valuation checks. At the same time, the company has a relatively modest 12.3% profit margin, ROE of 16.2%, and relies entirely on higher risk funding sources, which could matter if conditions tighten. For investors watching AI healthcare tools that already have real world clinical use, those trade offs may make ASO International worth a closer look.
ASO International’s AI orthodontics story is only half told, with modest margins alongside a stock assessed as below estimated fair value. Get the context behind that gap in the DCF valuation analysis for ASO International
eWeLLLtd (TSE:5038)
Overview: eWeLLLtd provides cloud based software for home based medical care in Japan, helping visiting nursing stations handle day to day work such as electronic medical records, insurance claims, staff attendance, administration, AI supported nursing reports, receivables financing, and e learning for legal training.
Operations: eWeLLLtd generates around ¥3.6b in revenue from providing services to home visit nursing stations in Japan.
Market Cap: ¥31.4b
eWeLLLtd brings together a focused business model and financial profile, with cloud tools that aim to simplify how Japan’s visiting nursing stations record care, claim insurance, pay staff, and train nurses. Earnings and revenue growth rates have recently been close to 20% per year, supported by net margins of about 31.5% and Return on Equity, although all liabilities are funded through higher risk borrowing rather than deposits. The stock currently trades below one estimate of fair value, yet carries a higher P/E than many Healthcare Services peers, which could matter if growth slows. Recent buybacks and a projected increase in the annual dividend are additional factors for investors considering eWeLLLtd in the AI healthcare space.
eWeLLLtd’s near 20% growth with wide margins and a richer P/E than many peers suggests the market already prices in a lot, but the full story sits in the analyst forecasts for eWeLLLtd
FINDEX (TSE:3649)
Overview: FINDEX is a Japan based health IT company that builds software and devices for hospitals and clinics, covering electronic medical records, imaging and document systems, data search, remote information sharing, ophthalmology tools, and generative AI solutions such as CocktailAI for medical text.
Operations: FINDEX generates most of its revenue from its Medical Business segment at approximately ¥5.8b, with smaller contributions from the Public Sector Business at about ¥0.3b and the Health Tech Business at around ¥0.1b, all reported in Japan.
Market Cap: ¥20.6b
FINDEX gives you broad exposure to hospital and clinic digitisation in Japan, with earnings reported as having grown around 22.4% per year over the past 5 years and forecasts indicating continued double digit gains that are slightly ahead of the wider market. Its P/E is reported as being below both the Asian Healthcare Services average and some peers, while the stock price is assessed as well below one estimate of fair value, which may appeal to investors who prioritise valuation support. At the same time, a funding mix built on higher risk external borrowing and questions over board independence introduce governance and balance sheet issues that are worth understanding before deciding how FINDEX fits into an AI healthcare portfolio.
FINDEX appears to be a hospital digitisation stock where earnings growth and a lower P/E could be masking what really matters next. It is therefore worth reading the analyst forecasts for FINDEX to see what the market might still be missing.
The three stocks covered here are only a starting point, as the full Transformative Artificial intelligence (AI) Healthcare Stocks screener surfaces 4 more companies with similarly compelling AI healthcare narratives that could widen your opportunity set. Use Simply Wall St to identify and analyze the exact catalysts that matter to you, from diagnostic accuracy and workflow efficiency to remote monitoring and research pipelines, so you can focus on the highest conviction plays in this theme.
Take Control of Your Investment Journey
If ASO International or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Curious About Seeking Powerful Alternatives?
Fresh stock ideas can move from quiet accumulation to breakout momentum fast, and the best entry points often pass before the crowd catches on. Getting in early can be important.
- Target dependable income streams and stress test your yield expectations with a curated set of 44 dividend fortresses that aim to keep paying while others are dropping.
- Spot early movers in automation and efficiency by zeroing in on 33 robotics and automation stocks where industrial and medical robotics could be building momentum under the radar for now.
- Track potential beneficiaries of infrastructure upgrades by scanning 36 power grid technology and infrastructure stocks that may gain from long term spending on transmission, stability, and grid modernisation before the crowd fully catches on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com